(Q35868196)

10 August 2017

1 reference

title

Non-stimulant medications in the treatment of ADHD. (English)

1 reference

10 August 2017

1

Tobias Banaschewski

0 references

Aribert Rothenberger

series ordinal

5

object named as

Aribert Rothenberger

0 references

Ralf W. Dittmann

series ordinal

3

object named as

Ralf W Dittmann

1 reference

10 August 2017

2

Veit Roessner

1 reference

10 August 2017

Paramala Janardhanan Santosh

series ordinal

4

1 reference

10 August 2017

1 January 2004

1 reference

European Child & Adolescent Psychiatry

10 August 2017

1 reference

10 August 2017

13 Suppl 1

1 reference

10 August 2017

I102-16

1 reference

https://scigraph.springernature.com/pub.10.1007/s00787-004-1010-x

10 August 2017

0 references

cites work

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

1 reference

12 December 2020

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

1 reference

12 December 2020

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

12 December 2020

Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy

1 reference

12 December 2020

An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder

1 reference

12 December 2020

The use of imipramine in children's behavior disorders

1 reference

12 December 2020

Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors

1 reference

12 December 2020

Disposition and metabolic fate of atomoxetine hydrochloride: the role of CYP2D6 in human disposition and metabolism

1 reference

12 December 2020

Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation

1 reference

12 December 2020

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

1 reference

12 December 2020

Motor performance in hyperactive children treated with imipramine

1 reference

12 December 2020

Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents

1 reference

12 December 2020

A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder

1 reference

12 December 2020

Imipramine in the Treatment of Minimal Brain Dysfunction in Children

1 reference

12 December 2020

Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient

1 reference

12 December 2020

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

12 December 2020

An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder

1 reference

12 December 2020

Nicotine dependence: the role for antidepressants and anxiolytics

1 reference

12 December 2020

Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes

1 reference

12 December 2020

Safety profile of atomoxetine in the treatment of children and adolescents with ADHD.

1 reference

12 December 2020

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

1 reference

12 December 2020

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1 reference

12 December 2020

Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression

1 reference

12 December 2020

Deprenyl in attention deficit associated with Tourette's syndrome

1 reference

12 December 2020

Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series

1 reference

12 December 2020

Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

1 reference

12 December 2020

An early phase II clinical trial of tomoxetine (LY139603) in the treatment of newly admitted depressed patients

1 reference

12 December 2020

A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine

1 reference

12 December 2020

Long-term prognosis in attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder

1 reference

12 December 2020

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity

1 reference

12 December 2020

Modafinil in children with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Catecholamines in attention-deficit hyperactivity disorder: current perspectives

1 reference

12 December 2020

Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity.

1 reference

12 December 2020

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Effects of Imipramine and Dextroamphetamine on Behavior of Neuropsychiatrically Impaired Children

1 reference

12 December 2020

Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children

1 reference

12 December 2020

The use of tricyclic antidepressants in children and adolescents

1 reference

12 December 2020

Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series

1 reference

12 December 2020

The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.

1 reference

12 December 2020

Bupropion in children with attention deficit disorder.

1 reference

12 December 2020

Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.

1 reference

12 December 2020

Attention-deficit hyperactivity disorder and hyperkinetic disorder

1 reference

12 December 2020

Nicotine effects on adults with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine.

1 reference

12 December 2020

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

12 December 2020

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

1 reference

12 December 2020

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

Changes in symptoms and adverse events after discontinuation of atomoxetine in children and adults with attention deficit/hyperactivity disorder: a prospective, placebo-controlled assessment.

1 reference

12 December 2020

The use of imipramine in Tourette's syndrome and attention deficit disorder: case report

1 reference

12 December 2020

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

1 reference

12 December 2020

An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents

1 reference

12 December 2020

Adult attention deficit hyperactivity disorder: psychological test profiles in a clinical population

1 reference

12 December 2020

Modification of hyperkinetic behavior by nortriptyline

1 reference

12 December 2020

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome

1 reference

12 December 2020

Treatment of ADHD with fluoxetine: a preliminary trial.

1 reference

12 December 2020

Use of moclobemide in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder

1 reference

12 December 2020

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

1 reference

12 December 2020

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

12 December 2020

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

12 December 2020

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

1 reference

12 December 2020

Questioning inhibitory control as the specific deficit of ADHD--evidence from brain electrical activity.

1 reference

12 December 2020

Response to methylphenidate in children with ADHD and comorbid anxiety

1 reference

12 December 2020

Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents

1 reference

12 December 2020

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

1 reference

12 December 2020

Effects of desipramine on autonomic control of the heart

1 reference

12 December 2020

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

12 December 2020

A naturalistic assessment of protriptyline for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Cardiovascular effects of atomoxetine in children, adolescents, and adults

1 reference

12 December 2020

1 reference

12 December 2020

Antidepressants in the treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

1 reference

12 December 2020

Treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

12 December 2020

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

12 December 2020

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

1 reference

12 December 2020

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

12 December 2020

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

12 December 2020

Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55.

1 reference

12 December 2020

Interpretations of cytochrome P450 mechanisms from kinetic studies

1 reference

12 December 2020

Bupropion treatment of attention-deficit hyperactivity disorder in adults

1 reference

12 December 2020

Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

An indication for use of imipramine in attention deficit disorder

1 reference

12 December 2020

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

12 December 2020

Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children

1 reference

12 December 2020

The stimulants revisited.

1 reference

12 December 2020

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Risk factors for severe bradycardia during oral clonidine therapy for hypertension

1 reference

12 December 2020

Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis

1 reference

12 December 2020

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.

1 reference

12 December 2020

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder

1 reference

12 December 2020

GW320659 for the treatment of attention-deficit/hyperactivity disorder in children

1 reference

12 December 2020

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

1 reference

12 December 2020

Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder.

1 reference

12 December 2020

The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults

1 reference

12 December 2020

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

1 reference

12 December 2020

Non-stimulant treatment of attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.

1 reference

12 December 2020

Side-effects of antidepressants.

1 reference

12 December 2020

Childhood behavior and learning problems treated with imipramine

1 reference

12 December 2020

Treatment of ADHD in children with tics: a randomized controlled trial

1 reference

12 December 2020

Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications

1 reference

12 December 2020

Non-stimulant treatments for ADHD.

1 reference

12 December 2020

Role of executive function in ADHD.

1 reference

12 December 2020

Imipramine and methylphenidate in hyperactive children

1 reference

12 December 2020

Four-year follow-up of children with low intelligence and ADHD: a replication

1 reference

12 December 2020

Propafenone for cardiac arrhythmias

1 reference

12 December 2020

Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases

1 reference

12 December 2020

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder

1 reference

12 December 2020

Appropriateness of psychostimulant prescription to children: theoretical and empirical perspectives

1 reference

12 December 2020

Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring

1 reference

12 December 2020

The Personality Inventory for Children and response to methylphenidate: preliminary evidence for predictive utility.

1 reference

12 December 2020

A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children

1 reference

12 December 2020

Open-label trial of venlafaxine in adults with attention deficit disorder.

1 reference

12 December 2020

A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings

1 reference

12 December 2020

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

12 December 2020

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

1 reference

12 December 2020

A review of stimulant drug research with hyperactive children

1 reference

12 December 2020

Does stimulant treatment lead to substance use disorders?

1 reference

12 December 2020

Identification of the human cytochromes P450 responsible for atomoxetine metabolism

1 reference

12 December 2020

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

12 December 2020

A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine

1 reference

12 December 2020

Regulation of extracellular dopamine by the norepinephrine transporter.

1 reference

12 December 2020

Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience

1 reference

12 December 2020

Combining methylphenidate and clonidine: a clinically sound medication option

1 reference

12 December 2020

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

1 reference

12 December 2020

Venlafaxine in children and adolescents with attention deficit hyperactivity disorder

1 reference

12 December 2020

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Association of ADHD and conduct disorder--brain electrical evidence for the existence of a distinct subtype.

1 reference

12 December 2020

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

1 reference

12 December 2020

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

12 December 2020

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

1 reference

12 December 2020

Effect of Clonidine on Atrioventricular Conduction

1 reference

12 December 2020

Multicenter P300 brain mapping of impaired attention to cues in hyperkinetic children.

1 reference

12 December 2020

Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children

1 reference

12 December 2020

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience

1 reference

12 December 2020

A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation

1 reference

12 December 2020

Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.

1 reference

12 December 2020

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

12 December 2020

Desipramine in the treatment of children with attention deficit disorder

1 reference

12 December 2020

Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.

1 reference

12 December 2020

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

1 reference

12 December 2020

A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder

1 reference

12 December 2020

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

12 December 2020

Case study: adverse response to clonidine

1 reference

12 December 2020

A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response

1 reference

12 December 2020

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

1 reference

12 December 2020

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

12 December 2020

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

1 reference

12 December 2020

How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis

1 reference

12 December 2020

Bupropion effects in attention deficit and conduct disorders.

1 reference

12 December 2020

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

12 December 2020

[Administration of moclobemide++ in children with attention deficit hyperactivity disorder ]

1 reference

12 December 2020

Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites

1 reference

12 December 2020

Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

1 reference

12 December 2020

Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults

1 reference

12 December 2020

Amitriptyline and methylphenidate treatment of behaviorally disordered children

1 reference

12 December 2020

Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics

1 reference

12 December 2020

Efficacy review of antipsychotics

1 reference

12 December 2020

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

12 December 2020

Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder

1 reference

12 December 2020

Sudden death in children receiving Norpramin: a review of three reported cases and commentary

1 reference

12 December 2020

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

12 December 2020

10.1007/S00787-004-1010-X

Identifiers

DOI

0 references

PubMed ID

15322961

1 reference

PubMed ID

15322961